fbpx
Industry > Altruism

Sale of Honda race car helps Laguna medical frontliners

Proceeds were used for PPEs and food packs

The sale of this championship-winning race car helped out medical frontliners. PHOTO BY SAM SURLA

Medical frontliners are the unsung heroes of these difficult times. And unlike some health official who cried wolf on national television for having been “destroyed” by the Commission on Audit, hospital workers toil long shifts and put on brave faces to help patients they don’t even know. Honda Cars Philippines recently did its part giving these dedicated staff members the help and the appreciation they truly deserve.

One of the ways the automaker made things happen was the recent sale of an open-wheel race car, the No. 16 Team Mugen SF13. This vehicle won the Japanese Super Formula Championship title in 2013. The car was brought to the Philippines in 2014 and toured select dealerships and motoring events before being put on display at Honda’s facility in Santa Rosa, Laguna.

As COVID cases continue to rise at an alarming rate, hospitals need all the help they can get. PHOTOS FROM HONDA

The proceeds were used for PPEs and food packs that were donated to the following Laguna hospitals:

  • The Medical City South Luzon
  • New Sinai MDI Hospital
  • Global Care Medical Center

In addition, Honda temporarily provided vehicles for use by staff members of the above-mentioned hospitals as well as these medical facilities:

  • Unihealth Southwoods Hospital and Medical Center
  • Perpetual Help Medical Center
  • Global Care Medical Center
  • Carmona Hospital and Medical Center

It’s time we all recognized the efforts of our medical personnel. Salute. And props to companies like Honda for helping them out.



Miggi Solidum

Miggi is an editor-at-large at VISOR. Professionally speaking, he is a software engineering dude who happens to like cars a lot. And as an automotive enthusiast, he wants a platform from which he can share his motoring thoughts with fellow petrolheads. He writes the 'G-Force' column.



Comments